Phenotypic Characterization of an α4 Neuronal Nicotinic Acetylcholine Receptor Subunit Knock-Out Mouse

Neuronal nicotinic acetylcholine receptors (nAChR) are present in high abundance in the nervous system (Decker et al., 1995). There are a large number of subunits expressed in the brain that combine to form multimeric functional receptors. We have generated an α4nAChR subunit knock-out line and focus on defining the behavioral role of this receptor subunit. Homozygous mutant mice (Mt) are normal in size, fertility, and home-cage behavior. Spontaneous unconditioned motor behavior revealed an ethogram characterized by significant increases in several topographies of exploratory behavior in Mt relative to wild-type mice (Wt) over the course of habituation to a novel environment. Furthermore, the behavior of Mt in the elevated plus-maze assay was consistent with increased basal levels of anxiety. In response to nicotine, Wt exhibited early reductions in a number of behavioral topographies, under both unhabituated and habituated conditions; conversely, heightened levels of behavioral topographies in Mt were reduced by nicotine in the late phase of the unhabituated condition. Ligand autoradiography confirmed the lack of high-affinity binding to radiolabeled nicotine, cytisine, and epibatidine in the thalamus, cortex, and caudate putamen, although binding to a number of discrete nuclei remained. The study confirms the pivotal role played by the α4 nAChR subunit in the modulation of a number of constituents of the normal mouse ethogram and in anxiety as assessed using the plus-maze. Furthermore, the response of Mt to nicotine administration suggests that persistent nicotine binding sites in the habenulo-interpeduncular system are sufficient to modulate motor activity in actively exploring mice.

[1]  M. Picciotto,et al.  Nicotinic Receptors in the Brain: Links between Molecular Biology and Behavior , 2000, Neuropsychopharmacology.

[2]  S. Shiffman,et al.  The effect of bupropion on nicotine craving and withdrawal , 2000, Psychopharmacology.

[3]  D. Sibley,et al.  Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase , 1999, Neuroscience.

[4]  A. Beaudet,et al.  Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  J. Changeux,et al.  Reduced antinociception in mice lacking neuronal nicotinic receptor subunits , 1999, Nature.

[6]  D. Sibley,et al.  Topographical evaluation of the phenotype of spontaneous behaviour in mice with targeted gene deletion of the D1A dopamine receptor: paradoxical elevation of grooming syntax , 1998, Neuropharmacology.

[7]  J. Changeux,et al.  Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice , 1998, The Journal of Neuroscience.

[8]  J. Changeux,et al.  Brain nicotinic receptors: structure and regulation, role in learning and reinforcement 1 Published on the World Wide Web on 24 October 1997. 1 , 1998, Brain Research Reviews.

[9]  J. Waddington,et al.  Heterogeneity of behavioural profile between three new putative selective D3 dopamine receptor antagonists using an ethologically based approach , 1998, Psychopharmacology.

[10]  R. Glennon,et al.  Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice. , 1998, The Journal of pharmacology and experimental therapeutics.

[11]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[12]  A. Beaudet,et al.  Mice Deficient in the α7 Neuronal Nicotinic Acetylcholine Receptor Lack α-Bungarotoxin Binding Sites and Hippocampal Fast Nicotinic Currents , 1997, The Journal of Neuroscience.

[13]  G. Donnan,et al.  Expression of Brain-Derived Neurotrophic Factor and TrkB Neurotrophin Receptors after Striatal Injury in the Mouse , 1997, Experimental Neurology.

[14]  R. Lester,et al.  Influence of Subunit Composition on Desensitization of Neuronal Acetylcholine Receptors at Low Concentrations of Nicotine , 1997, The Journal of Neuroscience.

[15]  D Bertrand,et al.  An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. , 1997, Human molecular genetics.

[16]  K. Kus,et al.  Pharmacological aspects of withdrawal from certain benzodiazepines. , 1992, Polish journal of pharmacology.

[17]  S. Arneric,et al.  The pharmacology of (-)-nicotine and novel cholinergic channel modulators. , 1997, Advances in pharmacology.

[18]  A. Beaudet,et al.  Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. , 1997, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  J. Changeux,et al.  Neuronal Nicotinic Receptor a6 Subunit mRNA is Selectively Concentrated in Catecholaminergic Nuclei of the Rat Brain , 1996, The European journal of neuroscience.

[20]  R. Olmstead,et al.  Efficacy of buspirone in smoking cessation: A placebo‐controlled trial , 1996, Clinical pharmacology and therapeutics.

[21]  M. Fiore,et al.  Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain , 1996, Psychopharmacology.

[22]  C. Vidal Nicotinic receptors in the brain , 1996, Molecular and chemical neuropathology.

[23]  I. Scheffer,et al.  A missense mutation in the neuronal nicotinic acetylcholine receptor α4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy , 1995, Nature Genetics.

[24]  J. Changeux,et al.  Identification of a New Component of the Agonist Binding Site of the Nicotinic 7 Homooligomeric Receptor (*) , 1995, The Journal of Biological Chemistry.

[25]  Michele Zoli,et al.  Abnormal avoidance learning in mice lacking functional high-affinity nicotine receptor in the brain , 1995, Nature.

[26]  S. Arneric,et al.  Diversity of neuronal nicotinic acetylcholine receptors: lessons from behavior and implications for CNS therapeutics. , 1995, Life sciences.

[27]  C. Gerfen,et al.  Altered striatal function in a mutant mouse lacking D1A dopamine receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Heinemann,et al.  α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells , 1994, Cell.

[29]  W K Bickel,et al.  Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. , 1994, Addiction.

[30]  M. Besson,et al.  Stimulation by nicotine of the spontaneous release of [3H]γ-aminobutyric acid in the substantia nigra and in the globus pallidus of the rat , 1994, Brain Research.

[31]  L. McMahon,et al.  Nicotinic receptor activation facilitates gabaergic neurotransmission in the avian lateral spiriform nucleus , 1994, Neuroscience.

[32]  S. Heinemann,et al.  Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. , 1994, Cell.

[33]  A. C. Collins,et al.  A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber , 1993, Pharmacology Biochemistry and Behavior.

[34]  J. Brioni,et al.  Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. , 1993, European journal of pharmacology.

[35]  C. Mulle,et al.  Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[36]  J. Changeux,et al.  Immunocytochemical localization of a neuronal nicotinic receptor: the beta 2-subunit , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  J. Hughes Tobacco withdrawal in self-quitters. , 1992, Journal of consulting and clinical psychology.

[38]  Cox Jl,et al.  Transdermal nicotine replacement and smoking cessation. , 1992 .

[39]  M. Sketch,et al.  Effect of buspirone on withdrawal symptoms associated with smoking cessation. , 1992, Archives of internal medicine.

[40]  J. P. Mckenna,et al.  Transdermal nicotine replacement and smoking cessation. , 1992, American family physician.

[41]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[42]  J R Hughes,et al.  Symptoms of tobacco withdrawal. A replication and extension. , 1991, Archives of general psychiatry.

[43]  E. Giacobini Nicotinic cholinergic receptors in human brain: effects of aging and Alzheimer. , 1991, Advances in experimental medicine and biology.

[44]  D. Bertrand,et al.  A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX , 1990, Neuron.

[45]  L. Swanson,et al.  The distribution of mRNA encoded by a new member of the neuronal nicotinic acetylcholine receptor gene family (α 5) in the rat central nervous system , 1990, Brain Research.

[46]  D. Bertrand,et al.  A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. , 1990, Neuron.

[47]  S. Heinemann,et al.  The functional diversity of the neuronal nicotinic acetylcholine receptors is increased by a novel subunit: β4 , 1989, Neuron.

[48]  J Patrick,et al.  Distribution of alpha2, alpha3, alpha4, and beta2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: A hybridization histochemical study in the rat , 1989, The Journal of comparative neurology.

[49]  C. Spielberger,et al.  Effects of smoking/nicotine on anxiety, heart rate, and lateralization of EEG during a stressful movie. , 1989, Psychophysiology.

[50]  B. Costall,et al.  The actions of nicotine and cocaine in a mouse model of anxiety , 1989, Pharmacology Biochemistry and Behavior.

[51]  L. Swanson,et al.  Beta 3: a new member of nicotinic acetylcholine receptor gene family is expressed in brain. , 1989, The Journal of biological chemistry.

[52]  D. Hatsukami,et al.  Signs and symptoms of tobacco withdrawal. , 1986, Archives of general psychiatry.

[53]  Pomerleau Of Nicotine as a psychoactive drug: anxiety and pain reduction. , 1986 .

[54]  O. Pomerleau Nicotine as a psychoactive drug: anxiety and pain reduction. , 1986, Psychopharmacology bulletin.

[55]  S. File,et al.  Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat , 1985, Journal of Neuroscience Methods.

[56]  P. Clarke,et al.  The effects of nicotine on locomotor activity in non‐tolerant and tolerant rats , 1983, British journal of pharmacology.

[57]  M. Aceto,et al.  Nicotine-induced antinociception in rats and mice: correlation with nicotine brain levels. , 1982, The Journal of pharmacology and experimental therapeutics.

[58]  D. Gilbert,et al.  Paradoxical tranquilizing and emotion-reducing effects of nicotine. , 1979, Psychological bulletin.

[59]  J. Stephenson,et al.  The occurrence of tolerance to a central depressant effect of nicotine , 1972, British journal of pharmacology.

[60]  Rudolf H. Moos,et al.  Differential effects of ward settings on psychiatric patients. A replication and extension. , 1967, The Journal of nervous and mental disease.